Medication info
Empogin 25 mg (Empagliflozin)

Empogin 25 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Pale yellow, double-convex, oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102109 · Approved 2021.03.05 · Insurance code 647805150

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in blood sugar control in adults with Type 2 diabetes
  • poor blood sugar control
  • cardiovascular disease
View approved original text

This medication is used in conjunction with dietary and exercise regimens to assist adults with Type 2 diabetes in controlling their blood sugar levels. It can be administered as monotherapy, and if blood sugar control is inadequate, it may be used in combination with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors. In particular, for Type 2 diabetes patients with cardiovascular disease, usage should be discussed with a specialist considering both blood sugar control and the impact on the occurrence of cardiovascular events. This medication helps improve overall blood sugar control and assists in diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, whether used as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, because efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment based on age is necessary. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiation of treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions, 4. General Precautions).

Precautions

This medication should not be used in certain patients. Individuals with allergies to the active substance or other ingredients should not take this medication. Patients with Type 1 diabetes or experiencing diabetic ketoacidosis should also avoid this medication. It is not administered to patients with severely impaired kidney function, those with end-stage kidney disease, or those undergoing dialysis. Additionally, as it contains lactose, patients with lactose intolerance or certain genetic metabolic disorders should not use this medication. Use with caution in patients with mild impairment of kidney function. If kidney function drops below a certain level, the dosage of this medication may need to be adjusted, or treatment should be discontinued. This medication is not effective in patients with end-stage kidney disease or those on dialysis. In heart failure patients with mild to moderate severity, this medication should be used with caution, and it is not recommended for patients with severe heart failure. When used with insulin or insulin secretagogues, there may be an increased risk of hypoglycemia; therefore, dosage adjustments of these medications may be necessary. Possible side effects of this medication include hypoglycemia, genital infections, urinary tract infections, increased urination, reduction in fluid volume, etc. Notably, hypoglycemia may occur more frequently when used in combination with insulin or sulfonylureas. Diabetic ketoacidosis, a serious metabolic acidosis, may rarely occur; if symptoms appear, immediate medical attention is required. Elderly patients or those at risk of fluid loss should be cautious for dehydration or low blood pressure, and this medication may be temporarily discontinued if necessary. Serious side effects such as liver damage or necrotizing fasciitis have also been reported, hence immediate consultation with a healthcare professional is advised if any unusual symptoms arise. Pregnant women are advised against using this medication, and breastfeeding women should also avoid taking it. The safety of this medication in children has not been established; hence, it should not be used in individuals under 18 years of age. No specific toxic reactions from overdose have been reported, but appropriate treatment may be required depending on clinical conditions. This medication may interact with other drugs, so inform your healthcare provider if you are taking any other medications. During treatment, take caution while driving or operating machinery due to the risk of hypoglycemia, particularly when used in combination with insulin. To use this medication safely, regular kidney function tests and monitoring for unusual symptoms are important.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvar dermatitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • itching
  • rash
  • urticaria
Show 225 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • acute pyelonephritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lower back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • rhegmatogenous retinal detachment
  • limb injury
  • road traffic accident
  • spleen injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • unstable angina
  • upper abdominal pain
  • cavities
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • passage of bloody stools
  • hemorrhoids
  • gastrointestinal bleeding
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • nasopharyngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • positional dizziness
  • sensory loss
  • paresthesia
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinson's disease
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • peculiar sensation
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • hyperactive bladder
  • renal mass
  • urine retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • hypoglycemia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • eye discomfort
  • conjunctival injection
  • eyelid swelling
  • visual impairment
  • floaters
  • vitreous hemorrhage
  • nasal bleeding
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • bruise
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • dizziness
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be stored at room temperature, between 1 to 30 degrees Celsius, and not too hot or cold.

Appearance and packaging

Appearance

Pale yellow, double-convex, oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.